Elucidating the therapeutic mechanism of Hengqing II decoction in Alzheimer's disease using network pharmacology and molecular docking techniques

汤剂 对接(动物) 药理学 机制(生物学) 计算生物学 化学 疾病 传统医学 生物 医学 内科学 哲学 认识论 护理部
作者
Yajing Wang,Jiahui Jiang,Shuyu Chen,Qian Chen,Xiaojing Yan,Xiaozhong Shen
出处
期刊:Fitoterapia [Elsevier]
卷期号:174: 105860-105860 被引量:1
标识
DOI:10.1016/j.fitote.2024.105860
摘要

The aim of our research was to investigate the mechanism of the Hengqing II decoction in treating Alzheimer's disease (AD) through network pharmacology and experimental validation methods. Firstly, the major chemical compounds of Hengqing II decoction were characterized by ultra-high-performance liquid chromatography-high resolution mass spectrometry (UHPLC-Q-TOF-MS/MS), and the gene sets related to AD treatment by Hengqing II decoction were collected through the database of PubChem, Swiss TargetPrediction, and DisGeNET. Secondly, a multi-level molecular network of "Traditional Chinese medicine (TCM)-compound-target-disease" was constructed and visualized using the STRING platform and Cytoscape 3.9.1 software, and the enrichment analysis based on the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway databases was performed to predict the potential active compounds and targets of Hengqing II decoction for treating AD. Finally, molecular docking simulation was applied to investigate the binding interactions between potential active compounds and key targets, and the western blotting technique was employed to examine the expression levels of AKT1, TNF-α, and NOS2 proteins affected by active compounds. Totally 120 compounds in Hengqing II decoction were characterized by UHPLC-Q-TOF-MS/MS. Network pharmacology results showed that potential active compounds in Hengqing II decoction in treating AD included catalpol, gastrodin, and rehmannioside D, etc., and the main target proteins were TNF-α, NOS2, and AKT1. Further functional enrichment analysis revealed that Hengqing II decoction mainly exerted its therapeutic effects on AD by regulating lipid and atherosclerosis signaling pathways, AD signaling pathways, AKT1 signaling pathways, and PTGS2 signaling pathways. Hengqing II decoction exerted therapeutic effects on AD through multi-component, multi-target, and multi-pathway regulation, and its action mechanisms were related to oxidative stress, neuroinflammation, autophagy, and other pathways. Our research laid the data foundation for further exploration of action mechanism and clarification of clinical positioning and provided new ideas and clues in TCM formula research.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zqh关闭了zqh文献求助
刚刚
Boro完成签到,获得积分10
刚刚
老肥发布了新的文献求助10
刚刚
1秒前
CipherSage应助科研通管家采纳,获得10
1秒前
pipiap发布了新的文献求助10
1秒前
酷波er应助科研通管家采纳,获得20
1秒前
1秒前
大模型应助科研通管家采纳,获得10
1秒前
CipherSage应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
大模型应助科研通管家采纳,获得10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
传奇3应助科研通管家采纳,获得10
1秒前
1秒前
Owen应助科研通管家采纳,获得10
1秒前
一灯大师发布了新的文献求助30
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
Jasper应助科研通管家采纳,获得10
2秒前
2秒前
Lucas应助乔乔兔采纳,获得10
2秒前
传奇3应助科研通管家采纳,获得10
2秒前
所所应助科研通管家采纳,获得10
2秒前
Owen应助科研通管家采纳,获得10
2秒前
BowieHuang应助科研通管家采纳,获得10
2秒前
Jasper应助科研通管家采纳,获得10
2秒前
wanci应助科研通管家采纳,获得10
2秒前
所所应助科研通管家采纳,获得10
2秒前
刻苦的白梅完成签到,获得积分10
2秒前
乐乐应助科研通管家采纳,获得10
2秒前
BowieHuang应助科研通管家采纳,获得10
2秒前
小马甲应助科研通管家采纳,获得10
2秒前
wanci应助科研通管家采纳,获得10
2秒前
搜集达人应助科研通管家采纳,获得10
2秒前
量子星尘发布了新的文献求助10
2秒前
共享精神应助科研通管家采纳,获得10
2秒前
小马甲应助科研通管家采纳,获得10
2秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Russian Foreign Policy: Change and Continuity 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5728317
求助须知:如何正确求助?哪些是违规求助? 5312368
关于积分的说明 15313794
捐赠科研通 4875546
什么是DOI,文献DOI怎么找? 2618882
邀请新用户注册赠送积分活动 1568431
关于科研通互助平台的介绍 1525095